Medicine. What are the right targets for psychopharmacology?
Hyman
Steven E
SE
Harvard University, Boston, MA 02138, USA.
Fenton
Wayne S
WS
D000818:Animals; D002986:Clinical Trials as Topic; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology; D015975:Consensus Development Conferences, NIH as Topic; D006801:Humans; D001523:Mental Disorders / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D009315:National Institute of Mental Health (U.S.); D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012559:Schizophrenia / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012565:Schizophrenic Psychology; D014481:United States
D011619:Psychotropic Drugs